Home › Companies › VERTEX PHARMACEUTICALS INC. › 2023-2024

VERTEX PHARMACEUTICALS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and VERTEX PHARMACEUTICALS INC.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

36Reported items
1,141Asset managers
20,293Fund votes
2024-05-15Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore VERTEX PHARMACEUTICALS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by VERTEX PHARMACEUTICALS INC.

These tallies are VERTEX PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

VERTEX PHARMACEUTICALS INC. — official shareholder meeting results, meeting held 2024-05-15
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Sangeeta Bhatia	221,206,626	808,512	182,981	--	11,540,149	Majority: yes
Elect Director: Lloyd Carney	213,533,037	8,478,558	186,524	--	11,540,149	Majority: yes
Elect Director: Alan Garber	220,695,587	1,315,689	186,843	--	11,540,149	Majority: yes
Elect Director: Reshma Kewalramani	221,328,875	695,546	173,698	--	11,540,149	Majority: yes
Elect Director: Michel Lagarde	221,776,280	234,937	186,902	--	11,540,149	Majority: yes
Elect Director: Jeffrey Leiden	217,823,643	4,195,522	178,954	--	11,540,149	Majority: yes
Elect Director: Diana McKenzie	218,220,365	3,797,695	180,059	--	11,540,149	Majority: yes
Elect Director: Bruce Sachs	207,616,033	14,397,759	184,327	--	11,540,149	Majority: yes
Elect Director: Jennifer Schneider	221,774,054	240,910	183,155	--	11,540,149	Majority: yes
Elect Director: Nancy Thornberry	221,772,658	241,378	184,083	--	11,540,149	Majority: yes
Elect Director: Suketu Upadhyay	221,237,300	770,815	190,004	--	11,540,149	Majority: yes
Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024:	229,460,523	3,987,619	290,126	--	0	Majority: yes
Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2023 compensation program for the Company's named executive officers:	202,098,575	19,223,784	875,760	--	11,540,149	Majority: yes
Proposal 4: Based upon the following votes, the shareholders approved a shareholder proposal regarding a special shareholder meeting improvement:	160,438,357	61,494,550	265,212	--	11,540,149	Majority: yes
Proposal 5: Based upon the following votes, the shareholders did not approve a shareholder proposal regarding a report on racial and gender pay gaps:	63,865,687	157,637,997	694,435	--	11,540,149	Majority: no

Source: VERTEX PHARMACEUTICALS INC., Form 8-K — read the filing on EDGAR.

How asset managers voted at the VERTEX PHARMACEUTICALS INC. 2023-2024 meeting

Each item below shows how the 1,141 asset managers that disclosed a VERTEX PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VERTEX PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote to approve named executive office compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 28 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%

FOR: 202,098,575AGAINST: 19,223,784

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2023 compensation program for the Company's named executive officers:”): 202,098,575 for, 19,223,784 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 78% for, 7% against (86% of the company cast a for/against vote).

The 1,123 asset managers below cast 94% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 94%

FOR: 94.3%AGAINST: 5.6%ABSTAIN: 0.1%NOT VOTED: 0.0%UNKNOWN: 0.0%

Largest asset managers voting on “Advisory vote to approve named executive office compensation.” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
Capital Group	45,719,167	0	For
Vanguard	25,534,121	0	For
Fidelity	22,938,843	0	For
BlackRock	18,168,149	1,073	For
Strategic Global Advisors, LLC	15,000,000	0	For
Capital Research Global Investors	11,994,183	0	For
State Street	10,736,994	0	For
JPMorgan	9,542,574	0	For
AllianceBernstein	6,990,481	0	For
T. Rowe Price	6,932,517	49,418	For
GEODE CAPITAL MANAGEMENT, LLC	5,783,458	0	For
JENNISON ASSOCIATES LLC	4,356,436	0	For
Wellington	4,189,872	0	For
Invesco	3,462,817	0	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	3,338,796	0	For
New York Life	3,111,776	0	For
Charles Schwab	3,088,901	0	For
Janus Henderson	2,615,016	0	For
Northern Trust	2,592,824	18,445	For
Clearbridge Investments, LLC	2,332,555	0	For
MFS	1,867,336	0	For
AB LARGE CAP GROWTH FUND INC	1,759,487	0	For
Amundi	0	1,744,641	Against
JANUS INVESTMENT FUND	1,728,087	0	For
UBS	0	1,698,922	Against

Showing the 25 largest of 1,123 asset managers. See all 1,123 in the interactive database.

2. Shareholder proposal, if properly presented at the meeting, regarding a report on racial and gender pay gaps.

DIVERSITY, EQUITY, AND INCLUSIONMajority of the votes cast: no

Meeting held 2024-05-15.

Combines 8 wordings of this item as funds reported it.

29% Majority: no · of votes cast

FOR 29%AGAINST 71%

FOR: 63,865,687AGAINST: 157,637,997

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 5: Based upon the following votes, the shareholders did not approve a shareholder proposal regarding a report on racial and gender pay gaps:”): 63,865,687 for, 157,637,997 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 25% for, 61% against (86% of the company cast a for/against vote).

The 230 asset managers below cast 8% of the shares they voted on this item FOR (9,460,516 for, 104,089,651 against).

8%AGAINST 91%

FOR: 9,460,516 (8.3%)AGAINST: 104,089,651 (91.3%)ABSTAIN: 480,900 (0.4%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Shareholder proposal, if properly presented at the meeting, regarding a report on racial and gender pay gaps.” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
Capital Group	0	26,513,674	Against
Vanguard	2,047	24,395,307	Against
Fidelity	4,438	13,041,186	Against
BlackRock	3,926	8,839,122	Against
JPMorgan	8,380	4,387,967	Against
State Street	987	3,011,613	Against
T. Rowe Price	0	2,295,656	Against
MFS	0	1,867,336	Against
AB LARGE CAP GROWTH FUND INC	1,759,487	0	For
JANUS INVESTMENT FUND	1,497,107	230,980	For
Invesco	0	1,589,208	Against
Charles Schwab	0	1,526,342	Against
INVESTMENT CO OF AMERICA	0	1,455,066	Against
Prudential/PGIM	0	1,265,327	Against
Columbia Threadneedle	736,528	380,655	For
HARBOR FUNDS	0	1,013,516	Against
NEW ECONOMY FUND	0	994,250	Against
Legg Mason	852,587	0	For
Loomis Sayles	0	827,167	Against
TIAA	816,903	0	For
AMCAP FUND	0	798,032	Against
Jackson National	11,836	700,382	Against
American Century	0	611,130	Against
PIONEER FUND /MA/	0	607,746	Against
Hartford	148	589,685	Against

Showing the 25 largest of 230 asset managers. See all 230 in the interactive database.

3. Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 9 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 229,460,523AGAINST: 3,987,619

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024:”): 229,460,523 for, 3,987,619 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 89% for, 2% against (90% of the company cast a for/against vote).

The 226 asset managers below cast 99.9% of the shares they voted on this item FOR (117,760,999 for, 24,301 against).

FOR 99.9%

FOR: 117,760,999 (99.9%)AGAINST: 24,301 (0.0%)ABSTAIN: 47,699 (0.0%)UNKNOWN: 100 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending Decembe” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
Capital Group	26,513,674	0	For
Vanguard	24,397,354	0	For
Fidelity	13,045,624	0	For
BlackRock	8,843,048	0	For
JPMorgan	4,396,347	0	For
RWC Asset Management LLP	3,931,547	0	For
State Street	3,012,499	101	For
T. Rowe Price	2,295,656	0	For
MFS	1,867,336	0	For
AB LARGE CAP GROWTH FUND INC	1,759,487	0	For
JANUS INVESTMENT FUND	1,728,087	0	For
Invesco	1,589,208	0	For
Charles Schwab	1,526,342	0	For
INVESTMENT CO OF AMERICA	1,455,066	0	For
Prudential/PGIM	1,265,327	0	For
Columbia Threadneedle	1,117,183	0	For
HARBOR FUNDS	1,013,516	0	For
NEW ECONOMY FUND	994,250	0	For
Legg Mason	852,587	0	For
Loomis Sayles	827,167	0	For
TIAA	816,903	0	For
AMCAP FUND	798,032	0	For
Jackson National	712,218	0	For
American Century	611,130	0	For
PIONEER FUND /MA/	607,746	0	For

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

4. Election of Directors: Sangeeta Bhatia

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 221,206,626AGAINST: 808,512

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Sangeeta Bhatia”): 221,206,626 for, 808,512 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 86% for, 0.4% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,834,262 for, 17,877 against).

FOR 99.9%

FOR: 113,834,262 (99.9%)AGAINST: 17,877 (0.0%)ABSTAIN: 44,898 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Sangeeta Bhatia” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Capital Group	26,513,674	For
Vanguard	24,397,354	For
Fidelity	13,045,624	For
BlackRock	8,843,048	For
JPMorgan	4,396,347	For
State Street	3,012,600	For
T. Rowe Price	2,295,656	For
MFS	1,867,336	For
AB LARGE CAP GROWTH FUND INC	1,759,487	For
JANUS INVESTMENT FUND	1,728,087	For
Invesco	1,589,208	For
Charles Schwab	1,526,342	For
INVESTMENT CO OF AMERICA	1,455,066	For
Prudential/PGIM	1,265,327	For
Columbia Threadneedle	1,117,183	For
HARBOR FUNDS	1,013,516	For
NEW ECONOMY FUND	994,250	For
Legg Mason	852,587	For
Loomis Sayles	827,167	For
TIAA	816,903	For
AMCAP FUND	798,032	For
Jackson National	712,218	For
American Century	611,130	For
PIONEER FUND /MA/	607,746	For
Hartford	589,833	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

5. Election of Directors: Lloyd Carney

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 213,533,037AGAINST: 8,478,558

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Lloyd Carney”): 213,533,037 for, 8,478,558 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 83% for, 3% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 97% of the shares they voted on this item FOR (110,509,773 for, 3,342,434 against).

FOR 97%

FOR: 110,509,773 (97.0%)AGAINST: 3,342,434 (2.9%)ABSTAIN: 44,898 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Lloyd Carney” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
Capital Group	26,513,674	0	For
Vanguard	22,006,289	2,391,065	For
Fidelity	13,026,393	19,231	For
BlackRock	8,843,048	0	For
JPMorgan	4,396,347	0	For
State Street	3,012,600	0	For
T. Rowe Price	2,295,656	0	For
MFS	1,867,336	0	For
AB LARGE CAP GROWTH FUND INC	1,759,487	0	For
JANUS INVESTMENT FUND	1,728,087	0	For
Invesco	1,589,208	0	For
Charles Schwab	1,526,342	0	For
INVESTMENT CO OF AMERICA	1,455,066	0	For
Prudential/PGIM	1,265,327	0	For
Columbia Threadneedle	1,117,183	0	For
HARBOR FUNDS	1,013,516	0	For
NEW ECONOMY FUND	994,250	0	For
Legg Mason	852,587	0	For
Loomis Sayles	827,167	0	For
TIAA	816,903	0	For
AMCAP FUND	798,032	0	For
Jackson National	712,218	0	For
American Century	611,130	0	For
PIONEER FUND /MA/	607,746	0	For
Hartford	148	589,685	Against

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

6. Election of Directors: Alan Garber

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 220,695,587AGAINST: 1,315,689

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Alan Garber”): 220,695,587 for, 1,315,689 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 85% for, 0.6% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,845,227 for, 7,065 against).

FOR 99.9%

FOR: 113,845,227 (100.0%)AGAINST: 7,065 (0.0%)ABSTAIN: 44,898 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Alan Garber” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Capital Group	26,513,674	For
Vanguard	24,397,354	For
Fidelity	13,045,624	For
BlackRock	8,843,048	For
JPMorgan	4,396,347	For
State Street	3,012,600	For
T. Rowe Price	2,295,656	For
MFS	1,867,336	For
AB LARGE CAP GROWTH FUND INC	1,759,487	For
JANUS INVESTMENT FUND	1,728,087	For
Invesco	1,589,208	For
Charles Schwab	1,526,342	For
INVESTMENT CO OF AMERICA	1,455,066	For
Prudential/PGIM	1,265,327	For
Columbia Threadneedle	1,117,183	For
HARBOR FUNDS	1,013,516	For
NEW ECONOMY FUND	994,250	For
Legg Mason	852,587	For
Loomis Sayles	827,167	For
TIAA	816,903	For
AMCAP FUND	798,032	For
Jackson National	712,218	For
American Century	611,130	For
PIONEER FUND /MA/	607,746	For
Hartford	589,833	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

7. Election of Directors: Reshma Kewalramani

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 5 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 221,328,875AGAINST: 695,546

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Reshma Kewalramani”): 221,328,875 for, 695,546 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 86% for, 0.3% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,846,911 for, 7,030 against).

FOR 99.9%

FOR: 113,846,911 (100.0%)AGAINST: 7,030 (0.0%)ABSTAIN: 44,897 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Reshma Kewalramani” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Capital Group	26,513,674	For
Vanguard	24,397,354	For
Fidelity	13,045,624	For
BlackRock	8,843,048	For
JPMorgan	4,396,347	For
State Street	3,012,600	For
T. Rowe Price	2,295,656	For
MFS	1,867,336	For
AB LARGE CAP GROWTH FUND INC	1,759,487	For
JANUS INVESTMENT FUND	1,728,087	For
Invesco	1,589,208	For
Charles Schwab	1,526,342	For
INVESTMENT CO OF AMERICA	1,455,066	For
Prudential/PGIM	1,265,327	For
Columbia Threadneedle	1,117,183	For
HARBOR FUNDS	1,013,516	For
NEW ECONOMY FUND	994,250	For
Legg Mason	852,587	For
Loomis Sayles	827,167	For
TIAA	816,903	For
AMCAP FUND	798,032	For
Jackson National	712,218	For
American Century	611,130	For
PIONEER FUND /MA/	607,746	For
Hartford	589,833	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

8. Election of Directors: Michel Lagarde

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 221,776,280AGAINST: 234,937

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michel Lagarde”): 221,776,280 for, 234,937 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 86% for, 0.1% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,846,945 for, 7,029 against).

FOR 99.9%

FOR: 113,846,945 (100.0%)AGAINST: 7,029 (0.0%)ABSTAIN: 44,898 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Michel Lagarde” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Capital Group	26,513,674	For
Vanguard	24,397,354	For
Fidelity	13,045,624	For
BlackRock	8,843,048	For
JPMorgan	4,396,347	For
State Street	3,012,600	For
T. Rowe Price	2,295,656	For
MFS	1,867,336	For
AB LARGE CAP GROWTH FUND INC	1,759,487	For
JANUS INVESTMENT FUND	1,728,087	For
Invesco	1,589,208	For
Charles Schwab	1,526,342	For
INVESTMENT CO OF AMERICA	1,455,066	For
Prudential/PGIM	1,265,327	For
Columbia Threadneedle	1,117,183	For
HARBOR FUNDS	1,013,516	For
NEW ECONOMY FUND	994,250	For
Legg Mason	852,587	For
Loomis Sayles	827,167	For
TIAA	816,903	For
AMCAP FUND	798,032	For
Jackson National	712,218	For
American Century	611,130	For
PIONEER FUND /MA/	607,746	For
Hartford	589,833	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

9. Election of Directors: Jeffrey Leiden

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 217,823,643AGAINST: 4,195,522

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeffrey Leiden”): 217,823,643 for, 4,195,522 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 84% for, 2% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,792,574 for, 61,452 against).

FOR 99.9%

FOR: 113,792,574 (99.9%)AGAINST: 61,452 (0.1%)ABSTAIN: 44,897 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Jeffrey Leiden” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
Capital Group	26,513,674	0	For
Vanguard	24,397,207	147	For
Fidelity	13,045,624	0	For
BlackRock	8,843,048	0	For
JPMorgan	4,396,347	0	For
State Street	3,012,575	25	For
T. Rowe Price	2,295,656	0	For
MFS	1,867,336	0	For
AB LARGE CAP GROWTH FUND INC	1,759,487	0	For
JANUS INVESTMENT FUND	1,728,087	0	For
Invesco	1,589,208	0	For
Charles Schwab	1,526,342	0	For
INVESTMENT CO OF AMERICA	1,455,066	0	For
Prudential/PGIM	1,265,327	0	For
Columbia Threadneedle	1,117,183	0	For
HARBOR FUNDS	1,013,516	0	For
NEW ECONOMY FUND	994,250	0	For
Legg Mason	852,587	0	For
Loomis Sayles	827,167	0	For
TIAA	816,903	0	For
AMCAP FUND	798,032	0	For
Jackson National	712,218	0	For
American Century	611,130	0	For
PIONEER FUND /MA/	607,746	0	For
Hartford	589,833	0	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

10. Election of Directors: Diana McKenzie

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 218,220,365AGAINST: 3,797,695

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Diana McKenzie”): 218,220,365 for, 3,797,695 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 84% for, 1% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,836,061 for, 17,982 against).

FOR 99.9%

FOR: 113,836,061 (99.9%)AGAINST: 17,982 (0.0%)ABSTAIN: 44,898 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Diana McKenzie” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Capital Group	26,513,674	For
Vanguard	24,397,354	For
Fidelity	13,045,624	For
BlackRock	8,843,048	For
JPMorgan	4,396,347	For
State Street	3,012,600	For
T. Rowe Price	2,295,656	For
MFS	1,867,336	For
AB LARGE CAP GROWTH FUND INC	1,759,487	For
JANUS INVESTMENT FUND	1,728,087	For
Invesco	1,589,208	For
Charles Schwab	1,526,342	For
INVESTMENT CO OF AMERICA	1,455,066	For
Prudential/PGIM	1,265,327	For
Columbia Threadneedle	1,117,183	For
HARBOR FUNDS	1,013,516	For
NEW ECONOMY FUND	994,250	For
Legg Mason	852,587	For
Loomis Sayles	827,167	For
TIAA	816,903	For
AMCAP FUND	798,032	For
Jackson National	712,218	For
American Century	611,130	For
PIONEER FUND /MA/	607,746	For
Hartford	589,833	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

11. Election of Directors: Bruce Sachs

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 207,616,033AGAINST: 14,397,759

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Bruce Sachs”): 207,616,033 for, 14,397,759 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 80% for, 6% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.4% of the shares they voted on this item FOR (113,237,591 for, 616,368 against).

FOR 99.4%

FOR: 113,237,591 (99.4%)AGAINST: 616,368 (0.5%)ABSTAIN: 44,898 (0.0%)UNKNOWN: 100 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Bruce Sachs” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
Capital Group	26,513,674	0	For
Vanguard	24,397,354	0	For
Fidelity	13,045,624	0	For
BlackRock	8,843,048	0	For
JPMorgan	4,396,347	0	For
State Street	3,012,499	101	For
T. Rowe Price	2,295,656	0	For
MFS	1,867,336	0	For
AB LARGE CAP GROWTH FUND INC	1,759,487	0	For
JANUS INVESTMENT FUND	1,728,087	0	For
Invesco	1,589,208	0	For
Charles Schwab	1,526,342	0	For
INVESTMENT CO OF AMERICA	1,455,066	0	For
Prudential/PGIM	1,265,327	0	For
Columbia Threadneedle	1,117,183	0	For
HARBOR FUNDS	1,013,516	0	For
NEW ECONOMY FUND	994,250	0	For
Legg Mason	852,587	0	For
Loomis Sayles	827,167	0	For
TIAA	816,903	0	For
AMCAP FUND	798,032	0	For
Jackson National	712,218	0	For
American Century	611,130	0	For
PIONEER FUND /MA/	607,746	0	For
Hartford	589,833	0	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

12. Election of Directors: Jennifer Schneider

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 221,774,054AGAINST: 240,910

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jennifer Schneider”): 221,774,054 for, 240,910 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 86% for, 0.1% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,846,980 for, 7,029 against).

FOR 99.9%

FOR: 113,846,980 (100.0%)AGAINST: 7,029 (0.0%)ABSTAIN: 44,898 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Jennifer Schneider” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Capital Group	26,513,674	For
Vanguard	24,397,354	For
Fidelity	13,045,624	For
BlackRock	8,843,048	For
JPMorgan	4,396,347	For
State Street	3,012,600	For
T. Rowe Price	2,295,656	For
MFS	1,867,336	For
AB LARGE CAP GROWTH FUND INC	1,759,487	For
JANUS INVESTMENT FUND	1,728,087	For
Invesco	1,589,208	For
Charles Schwab	1,526,342	For
INVESTMENT CO OF AMERICA	1,455,066	For
Prudential/PGIM	1,265,327	For
Columbia Threadneedle	1,117,183	For
HARBOR FUNDS	1,013,516	For
NEW ECONOMY FUND	994,250	For
Legg Mason	852,587	For
Loomis Sayles	827,167	For
TIAA	816,903	For
AMCAP FUND	798,032	For
Jackson National	712,218	For
American Century	611,130	For
PIONEER FUND /MA/	607,746	For
Hartford	589,833	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

13. Election of Directors: Nancy Thornberry

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 221,772,658AGAINST: 241,378

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Nancy Thornberry”): 221,772,658 for, 241,378 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 86% for, 0.1% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,845,144 for, 7,029 against).

FOR 99.9%

FOR: 113,845,144 (100.0%)AGAINST: 7,029 (0.0%)ABSTAIN: 44,898 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Nancy Thornberry” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Capital Group	26,513,674	For
Vanguard	24,397,354	For
Fidelity	13,045,624	For
BlackRock	8,843,048	For
JPMorgan	4,396,347	For
State Street	3,012,600	For
T. Rowe Price	2,295,656	For
MFS	1,867,336	For
AB LARGE CAP GROWTH FUND INC	1,759,487	For
JANUS INVESTMENT FUND	1,728,087	For
Invesco	1,589,208	For
Charles Schwab	1,526,342	For
INVESTMENT CO OF AMERICA	1,455,066	For
Prudential/PGIM	1,265,327	For
Columbia Threadneedle	1,117,183	For
HARBOR FUNDS	1,013,516	For
NEW ECONOMY FUND	994,250	For
Legg Mason	852,587	For
Loomis Sayles	827,167	For
TIAA	816,903	For
AMCAP FUND	798,032	For
Jackson National	712,218	For
American Century	611,130	For
PIONEER FUND /MA/	607,746	For
Hartford	589,833	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

14. Election of Directors: Suketu Upadhyay

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 221,237,300AGAINST: 770,815

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Suketu Upadhyay”): 221,237,300 for, 770,815 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 86% for, 0.3% against (86% of the company cast a for/against vote).

The 223 asset managers below cast 99.9% of the shares they voted on this item FOR (113,845,087 for, 7,034 against).

FOR 99.9%

FOR: 113,845,087 (100.0%)AGAINST: 7,034 (0.0%)ABSTAIN: 44,898 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Election of Directors: Suketu Upadhyay” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Capital Group	26,513,674	For
Vanguard	24,397,354	For
Fidelity	13,045,624	For
BlackRock	8,843,048	For
JPMorgan	4,396,347	For
State Street	3,012,600	For
T. Rowe Price	2,295,656	For
MFS	1,867,336	For
AB LARGE CAP GROWTH FUND INC	1,759,487	For
JANUS INVESTMENT FUND	1,728,087	For
Invesco	1,589,208	For
Charles Schwab	1,526,342	For
INVESTMENT CO OF AMERICA	1,455,066	For
Prudential/PGIM	1,265,327	For
Columbia Threadneedle	1,117,183	For
HARBOR FUNDS	1,013,516	For
NEW ECONOMY FUND	994,250	For
Legg Mason	852,587	For
Loomis Sayles	827,167	For
TIAA	816,903	For
AMCAP FUND	798,032	For
Jackson National	712,218	For
American Century	611,130	For
PIONEER FUND /MA/	607,746	For
Hartford	589,833	For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

15. Shareholder proposal, if properly presented at the meeting, regarding special shareholder meeting improvement.

SHAREHOLDER RIGHTS AND DEFENSESMajority of the votes cast: yes

Meeting held 2024-05-15.

Combines 5 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%AGAINST 28%

FOR: 160,438,357AGAINST: 61,494,550

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders approved a shareholder proposal regarding a special shareholder meeting improvement:”): 160,438,357 for, 61,494,550 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 62% for, 24% against (86% of the company cast a for/against vote).

The 216 asset managers below cast 73% of the shares they voted on this item FOR (76,599,287 for, 27,888,626 against).

FOR 73%AGAINST 27%

FOR: 76,599,287 (73.3%)AGAINST: 27,888,626 (26.7%)ABSTAIN: 66,619 (0.1%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Shareholder proposal, if properly presented at the meeting, regarding special shareholder meeting improvement.” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
Capital Group	26,513,674	0	For
Vanguard	23,916,906	480,447	For
Fidelity	146,727	12,898,897	Against
JPMorgan	0	4,396,347	Against
State Street	3,012,021	579	For
T. Rowe Price	14,199	2,281,457	Against
MFS	1,867,336	0	For
AB LARGE CAP GROWTH FUND INC	1,759,487	0	For
JANUS INVESTMENT FUND	1,497,107	230,980	For
Invesco	0	1,589,208	Against
Charles Schwab	0	1,526,342	Against
INVESTMENT CO OF AMERICA	1,455,066	0	For
Prudential/PGIM	173,762	1,091,565	Against
Columbia Threadneedle	1,117,183	0	For
HARBOR FUNDS	0	1,013,516	Against
NEW ECONOMY FUND	994,250	0	For
Legg Mason	852,587	0	For
Loomis Sayles	827,167	0	For
TIAA	816,903	0	For
AMCAP FUND	798,032	0	For
Jackson National	484,422	227,796	For
American Century	611,130	0	For
PIONEER FUND /MA/	607,746	0	For
Hartford	589,833	0	For
Victory Capital	523,753	0	For

Showing the 25 largest of 216 asset managers. See all 216 in the interactive database.

16. Reduce Ownership Threshold for Shareholders to Call Special Meeting

CORPORATE GOVERNANCE

Meeting held 2024-05-15.

1% fund support · no official result

AGAINST 99%

The 11 asset managers below cast 1% of the shares they voted on this item FOR (93,966 for, 9,247,765 against).

FOR: 93,966 (1.0%)AGAINST: 9,247,765 (99.0%)ABSTAIN: 594 (0.0%)

Largest asset managers voting on “Reduce Ownership Threshold for Shareholders to Call Special Meeting” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
BlackRock	8,678	8,834,370	0	Against
MASTER INVESTMENT PORTFOLIO	0	404,666	0	Against
Empower	56,491	0	0	For
Lincoln Financial	14,406	0	0	For
Aspiration Funds	9,372	0	0	For
Managed Account Series	0	8,211	0	Against
Brighthouse	4,003	0	0	For
Symmetry Panoramic Trust	0	518	594	Abstain
Tidal Trust III	651	0	0	For
Warren Street Wealth Advisors, LLC	205	0	0	For
RWC Asset Management LLP	160	0	0	For

17. S/H Proposal - Corporate Governance

CORPORATE GOVERNANCE

Meeting held 2024-05-15.

Combines 3 wordings of this item as funds reported it.

96% fund support · no official result

FOR 94%

The 4 asset managers below cast 96% of the shares they voted on this item FOR (2,275 for, 89 against).

FOR: 2,275 (94.2%)AGAINST: 89 (3.7%)ABSTAIN: 50 (2.1%)

Largest asset managers voting on “S/H Proposal - Corporate Governance” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Williamson Legacy Group, LLC	2,247	0	0	For
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	28	71	0	Against
HARBOUR INVESTMENT MANAGEMENT LLC	0	0	50	Abstain
Members Trust Co	0	18	0	Against

18. Advisory Vote To Approve Named Executive Office Compensation.

SECTION 14A SAY-ON-PAY VOTES

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (22,570 for, 0 against).

FOR: 22,570 (100.0%)

Largest asset managers voting on “Advisory Vote To Approve Named Executive Office Compensation.” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Lincoln Financial	17,615	For
F/M Investments LLC	3,745	For
Federated Hermes	1,210	For

19. Advisory vote to approve named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-14 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 208,886,386AGAINST: 17,048,300

VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2024 compensation program for the Company's named executive officers:”): 208,886,386 for, 17,048,300 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 258,296,249 outstanding shares: 81% for, 7% against (87% of the company cast a for/against vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (28,695 for, 0 against).

FOR 100%

FOR: 28,695 (100.0%)

Largest asset managers voting on “Advisory vote to approve named executive officer compensation.” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Foster Victor Wealth Advisors, LLC	23,406	For
Freedom Day Solutions, LLC	5,225	For
Weil Company, Inc.	64	For

20. Election of Directors (Majority Voting)

DIRECTOR ELECTIONS

Meeting held 2024-05-15.

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR.

FOR: 100.0%

Largest asset managers voting on “Election of Directors (Majority Voting)” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Williamson Legacy Group, LLC	2,247	For
HARBOUR INVESTMENT MANAGEMENT LLC	550	For
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	99	For

21. Election Of Director: Alan Garber

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Alan Garber” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

22. Election Of Director: Bruce Sachs

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Bruce Sachs” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

23. Election Of Director: Diana Mckenzie

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Diana Mckenzie” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

24. Election Of Director: Jeffrey Leiden

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Jeffrey Leiden” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

25. Election Of Director: Jennifer Schneider

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Jennifer Schneider” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

26. Election Of Director: Lloyd Carney

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

6% fund support · no official result

AGAINST 94%

The 2 asset managers below cast 6% of the shares they voted on this item FOR (1,210 for, 17,615 against).

FOR: 1,210 (6.4%)AGAINST: 17,615 (93.6%)

Largest asset managers voting on “Election Of Director: Lloyd Carney” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	0	17,615	0	0	Against
Federated Hermes	1,210	0	0	0	For

27. Election Of Director: Michel Lagarde

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Michel Lagarde” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

28. Election Of Director: Nancy Thornberry

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Nancy Thornberry” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

29. Election Of Director: Reshma Kewalramani

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Reshma Kewalramani” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

30. Election Of Director: Sangeeta Bhatia

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Sangeeta Bhatia” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

31. Election Of Director: Suketu Upadhyay

DIRECTOR ELECTIONS

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Election Of Director: Suketu Upadhyay” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

32. Ratification Of Ernst & Young LLP As Independent Registered Public Accounting Firm For The Year Ending December 31, 2024.

AUDIT-RELATED

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Ratification Of Ernst & Young LLP As Independent Registered Public Accounting Firm For The Year Ending Decembe” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

33. Shareholder Proposal, If Properly Presented At The Meeting, Regarding A Report On Racial And Gender Pay Gaps.

DIVERSITY, EQUITY, AND INCLUSION

Reported under meeting date 2024-03-18; no official results on file for that date.

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 18,825 against).

AGAINST: 18,825 (100.0%)

Largest asset managers voting on “Shareholder Proposal, If Properly Presented At The Meeting, Regarding A Report On Racial And Gender Pay Gaps.” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	0	17,615	0	0	Against
Federated Hermes	0	1,210	0	0	Against

34. Shareholder Proposal, If Properly Presented At The Meeting, Regarding Special Shareholder Meeting Improvement.

SHAREHOLDER RIGHTS AND DEFENSES

Reported under meeting date 2024-03-18; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,825 for, 0 against).

FOR: 18,825 (100.0%)

Largest asset managers voting on “Shareholder Proposal, If Properly Presented At The Meeting, Regarding Special Shareholder Meeting Improvement.” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Lincoln Financial	17,615	0	0	0	For
Federated Hermes	1,210	0	0	0	For

35. Amend Articles/Bylaws/Charter - Call Special Meetings

CORPORATE GOVERNANCE

Meeting held 2024-05-15.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (2,771 for, 0 against).

FOR: 2,771 (100.0%)

Largest asset managers voting on “Amend Articles/Bylaws/Charter - Call Special Meetings” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Advisors' Inner Circle Fund III	2,735	0	0	0	For
Two Roads Shared Trust	36	0	0	0	For

36. Elect Director

DIRECTOR ELECTIONS

Meeting held 2024-05-15.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (2,771 for, 0 against).

FOR: 2,771 (100.0%)

Largest asset managers voting on “Elect Director” at VERTEX PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Advisors' Inner Circle Fund III	2,735	0	0	0	For
Two Roads Shared Trust	36	0	0	0	For

Largest VERTEX PHARMACEUTICALS INC. shareholders voting in 2023-2024

Ranked by the number of VERTEX PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 258,296,249 shares outstanding at the time of that meeting.

Top VERTEX PHARMACEUTICALS INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Capital Group	17.70%
2	Vanguard	9.89%
3	Fidelity	8.88%
4	BlackRock	7.03%
5	Strategic Global Advisors, LLC	5.81%
6	Capital Research Global Investors	4.64%
7	State Street	4.16%
8	JPMorgan	3.69%
9	AllianceBernstein	2.71%
10	T. Rowe Price	2.70%

Reported VERTEX PHARMACEUTICALS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

VERTEX PHARMACEUTICALS INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	9.38%	13F
BlackRock	8.62%	13F
Capital World Investors	8.55%	DEF14A
FMR LLC	5.03%	DEF14A
State Street	4.65%	13F
JPMorgan Chase	2.49%	13F
Geode Capital	2.25%	13F
Wellington Management	1.76%	13F
T. Rowe Price	1.74%	13F
FMR (Fidelity)	1.28%	13F

Percentages above are of 258,296,249 shares outstanding, as reported by VERTEX PHARMACEUTICALS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VERTEX PHARMACEUTICALS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At VERTEX PHARMACEUTICALS INC.'s shareholder meeting held 2024-05-15, in the 2023-2024 proxy season, 1,141 asset managers reported how they voted in their SEC Form N-PX filings, covering 20,293 separate fund positions. Their filings are grouped here into 36 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve named executive office compensation. — FOR was 91% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VERTEX PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

VERTEX PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.